These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19379066)

  • 1. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACC/AHA guideline update: treatment of heart failure with reduced left ventricular ejection fraction.
    Aronow WS
    Geriatrics; 2006 Mar; 61(3):22-9. PubMed ID: 16522132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diastolic dysfunction in hypertension.
    Ginelli P; Bella JN
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):613-8. PubMed ID: 22743209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic heart failure: an overview of conventional treatment versus novel approaches.
    Landmesser U; Drexler H
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):628-38. PubMed ID: 16306919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM
    Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
    Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
    Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.
    Aronow WS
    Cardiol Rev; 2006; 14(3):108-24. PubMed ID: 16628020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of congestive heart failure in the elderly patient.
    Aronow WS
    Compr Ther; 1995 Jul; 21(7):329-38. PubMed ID: 7554808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diastolic heart failure.
    Kazik A; Wilczek K; Poloński L
    Cardiol J; 2010; 17(6):558-65. PubMed ID: 21154257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
    J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.